The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase II efficacy trial of pazopanib in non-clear cell metastatic renal cell carcinoma (PINCR trial).
Brian Addis Costello
No relevant relationships to disclose
Thai Huu Ho
No relevant relationships to disclose
Winston Tan
No relevant relationships to disclose
Bradley C. Leibovich
No relevant relationships to disclose
Erik P. Castle
No relevant relationships to disclose
Alexander S. Parker
No relevant relationships to disclose
Roxana Stefania Dronca
No relevant relationships to disclose
Rui Qin
No relevant relationships to disclose
Manish Kohli
No relevant relationships to disclose